Michel Sadelain, MD PhD

Affiliations: 
Memorial Sloan-Kettering Institute 
Google:
"Michel Sadelain"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zakrzewski JL, Suh D, Markley JC, et al. (2024) Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology
Dobrin A, Lindenbergh PL, Shi Y, et al. (2024) Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature Cancer
Yi F, Cohen T, Zimmerman N, et al. (2024) CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit. Biorxiv : the Preprint Server For Biology
Stephan MT, Ponomarev V, Brentjens RJ, et al. (2024) Author Correction: T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine
Amor C, Feucht J, Leibold J, et al. (2024) Author Correction: Senolytic CAR T cells reverse senescence-associated pathologies. Nature
van der Stegen SJC, Lindenbergh PL, Petrovic RM, et al. (2024) Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. Nature Biomedical Engineering
Amor C, Fernández-Maestre I, Chowdhury S, et al. (2024) Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Nature Aging
Jain N, Zhao Z, Koche RP, et al. (2023) Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T cell function. Cancer Discovery
Hammer Q, Perica K, van Ooijen H, et al. (2023) Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells. Biorxiv : the Preprint Server For Biology
Amor C, Fernández-Maestre I, Chowdhury S, et al. (2023) Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Research Square
See more...